Pharmaceutical giant GlaxoSmithKline faces further accusations concerning disclosure of failed clinical trials related to the antidepressant Seroxat or Paxil . Some studies reveal that these types of anti-depressants should not be used on teenagers, due to an increase in suicidal behavior when the drugs are prescribed. The new accusations suggest that the drug manufacturer new about the link between the drug and suicidal behavior in teenagers and yet tried to market the drug as a beneficial anti-depressant for kids under 18.
Comments for this article are closed.